arginase 2 mitochondrial
Selected indexed studies
- Location Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease? (Cell Mol Gastroenterol Hepatol, 2024) [PMID:38471656]
- Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction. (Mol Metab, 2021) [PMID:34139341]
- Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism. (Cell Metab, 2024) [PMID:39116884]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism. (2024) pubmed
- Location Matters: Mitochondrial Arginase 2 as a Treatment for Metabolic Disease? (2024) pubmed
- Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction. (2021) pubmed
- Calbindin 2-specific deletion of arginase 2 preserves visual function after optic nerve crush. (2023) pubmed
- Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages. (2021) pubmed
- Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy. (2019) pubmed
- ESRRA-ATG5-Mediated mitophagy enhances arginine metabolism to alleviate diabetic kidney disease. (2026) pubmed
- Ammonia detoxification promotes CD8(+) T cell memory development by urea and citrulline cycles. (2023) pubmed
- Arginase-2 mediates renal ischemia-reperfusion injury. (2017) pubmed
- Mitochondrial arginase 2 regulates hematopoietic and cardiovascular adaptation to hypoxia. (2026) pubmed